Table 4 Treatment success among study subgroups
Subgroups | Studies | Treatment success |
|---|---|---|
| Â | (n) | (95% CI) |
Year study began | Â | Â |
2002 or later | 5 | 68% (59-75) |
Before 2002 | 5 | 63% (52-73) |
Patient’s age |  |  |
Included patients ≤14 years old | 6 | 67% (54-78) |
All patients >14Â years old | 4 | 65% (62-68) |
HIV prevalence | Â | Â |
0-2% | 4 | 72% (61-81) |
HIV > 2% | 2 | 85% (55-100) |
Not specified or unknown | 4 | 61% (46-75) |
XDRTB prevalence | Â | Â |
0% | 3 | 75% (55-91) |
>0% | 2 | 53% (26-78) |
Not specified or unknown | 5 | 67% (61-73) |
Treatment model | Â | Â |
Individualized | 6 | 65% (54-75) |
Standardized | 4 | 66% (60-71) |
DOTS location | Â | Â |
Included home-based option | 4 | 64% (61-68) |
Clinic or public health centre only | 4 | 63% (45-79) |
Not specified | 2 | 82% (54-98) |
DOTS provider | Â | Â |
Family members, neighbours or household members sometimes utilized | 3 | 62% (55-69) |
Only CHWs, HCWs and other medical practitioners | 7 | 66% (57-74) |